Clinical Research
Along with normal clinical service, wide range of clinical trials also provided in our center
We are actively recruiting patient to participate in the following clinical trials
Please send referral letter to medicaloncology@hku.hk if interested
Recruiting Clinical Trials
Liver Cancer
Protocol Number
Protocol Title
Experimental Agent
Principle Investigator
CA224-106
A Phase 1/2, Safety Confirmation and Double-blind, Placebo-controlled, Randomized Study of Relatlimab in Combination with Nivolumab and Bevacizumab in Treatment-naive Advanced/Metastatic Hepatocellular Carcinoma (RELATIVITY-106)
Relatilimab + Nivolumab + Bevacizumab
CO44668 (IMbrave152)
A Phase III, Randomized, Double-blind, Placebo-controlled Study Evaluation Atezolizumab and Bevacizumab, with or without Tiragolumab, in Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
Nivolumab + Bevacizumab +/- Tiragolumab
OTX-2002-101
A Phase 1/2 open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of OTX-2002 as a single agent and in combination with standard of care in patients with hepatocellular carcinoma and other solid tumor types known for association with the MYC oncogene.
OTX-2002